tradingkey.logo

tradingkey.logo
怜玢


Cosmos Health Inc

COSM
りォッチリストに远加
0.302USD
-0.005-1.57%
終倀 05/15, 16:00ET15分遅れの株䟡
15.33M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Cosmos Health Inc 䌁業名

Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.

Cosmos Health Incの䌁業情報


䌁業コヌドCOSM
䌚瀟名Cosmos Health Inc
䞊堎日May 19, 2010
最高経営責任者「CEO」Siokas (Grigorios)
埓業員数149
蚌刞皮類Ordinary Share
決算期末May 19
本瀟所圚地5 Agiou Georgiou, Pilea
郜垂THESSALONIKI
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Greece
郵䟿番号554 38
電話番号303125363102
りェブサむトhttps://www.cosmosholdingsinc.com/
䌁業コヌドCOSM
䞊堎日May 19, 2010
最高経営責任者「CEO」Siokas (Grigorios)

Cosmos Health Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
10.21M
+6.66%
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
1.22M
+40.25%
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
60.00K
+33.33%
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
45.00K
+33.33%
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
35.00K
+42.86%
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
30.00K
+50.00%
Mr. Nikos Bardakis
Mr. Nikos Bardakis
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Theodoros C. Karkantzos
Mr. Theodoros C. Karkantzos
Director
Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
10.21M
+6.66%
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
1.22M
+40.25%
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
60.00K
+33.33%
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
45.00K
+33.33%
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
35.00K
+42.86%
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
30.00K
+50.00%

収益内蚳

通貚: USD曎新時刻: Mon, Apr 6
通貚: USD曎新時刻: Mon, Apr 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
Greece
16.39M
95.77%
UK
512.54K
3.00%
United Arab Emirates (
118.40K
0.69%
Cyprus
56.93K
0.33%
Albania
23.41K
0.14%
他の
11.89K
0.07%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Sun, May 10
曎新時刻: Sun, May 10
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Siokas (Grigorios)
27.39%
Bovopoulos (Andreas D)
8.15%
Terzis (Georgios)
2.40%
Renaissance Technologies LLC
0.66%
BlackRock Institutional Trust Company, N.A.
0.53%
他の
60.88%
株䞻統蚈
株䞻統蚈
比率
Siokas (Grigorios)
27.39%
Bovopoulos (Andreas D)
8.15%
Terzis (Georgios)
2.40%
Renaissance Technologies LLC
0.66%
BlackRock Institutional Trust Company, N.A.
0.53%
他の
60.88%
皮類
株䞻統蚈
比率
Individual Investor
38.39%
Investment Advisor
1.09%
Hedge Fund
0.97%
Investment Advisor/Hedge Fund
0.52%
Venture Capital
0.20%
Research Firm
0.04%
Bank and Trust
0.01%
他の
58.77%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
39
1.44M
2.84%
-1.82M
2025Q4
39
1.21M
8.69%
--
2025Q3
40
1.21M
10.09%
+200.56K
2025Q2
40
1.01M
10.29%
-1.71M
2025Q1
38
2.72M
7.86%
+891.30K
2024Q4
38
1.62M
11.55%
-779.82K
2024Q3
39
2.40M
4.16%
+1.81M
2024Q2
40
591.35K
13.72%
-13.70K
2024Q1
40
605.05K
14.49%
-1.85M
2023Q4
39
1.97M
8.60%
+1.22M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Siokas (Grigorios)
8.86M
23.77%
+679.79K
+8.31%
Feb 12, 2026
Bovopoulos (Andreas D)
3.73M
10.01%
+2.28M
+156.94%
Mar 09, 2026
Terzis (Georgios)
727.26K
1.95%
--
--
Aug 01, 2025
Renaissance Technologies LLC
334.57K
0.9%
+241.78K
+260.53%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
267.80K
0.72%
--
--
Dec 31, 2025
Geode Capital Management, L.L.C.
198.68K
0.53%
--
--
Dec 31, 2025
Citadel Advisors LLC
123.16K
0.33%
-102.35K
-45.39%
Dec 31, 2025
XTX Markets LLC
99.61K
0.27%
+34.12K
+52.09%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
日付
配圓萜ち日
皮類
比率
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
Dec 15, 2022
Merger
25→1
KeyAI
î™